OVER A THOUSAND phase 1 through 4 clinical studies
Oncology and Rare Disease comprise the largest portion of our work, including late-phase trials.
- Rare Disease portfolio with broad experience across multiple therapeutic areas. Read More
- A wide variety of studies in hematological malignancies and solid tumor indications. Read More
- More than 20 NDA / MAA dossiers submitted to global regulatory authorities.
- Clinical development strategy and complex protocol design consultation across a variety of therapeutic areas.
Major Therapeutic Areas
Allergy/Pulmonology
Cardiology
Dermatology
Diagnosis & Imaging
Endocrinology
Gastroenterology
Hematology
Immunology & Inflammation
Infectious Disease
Medical Devices
Nephrology
Neurology
Oncology
Ophthalmology
Orthopedic
Pain Medicine
Pediatrics
Psychiatry
Rare Diseases
Rheumatology
Urology
Women's Health
FDA Interactions
PROMETRIKA PhD biostatisticians provide pre-meeting consultation/preparation and meeting participation/presentation for pre-IND, SPA, End-of-Phase 2, pre-NDA, and Advisory Committee meetings.